173 related articles for article (PubMed ID: 7546006)
1. Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 May; 12(4):335-40. PubMed ID: 7546006
[TBL] [Abstract][Full Text] [Related]
2. [Proton MR spectroscopy of the brain in patients with congenital myotonic dystrophy].
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
No To Hattatsu; 1995 May; 27(3):177-83. PubMed ID: 7662403
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury.
Ashwal S; Holshouser BA; Hinshaw DB; Schell RM; Bailey L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):403-14. PubMed ID: 8751509
[TBL] [Abstract][Full Text] [Related]
5. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
6. Proton MRS: N-acetyl aspartate, creatine, and choline.
Maton BM; Kuzniecky RI
Adv Neurol; 2000; 83():253-9. PubMed ID: 10999207
[No Abstract] [Full Text] [Related]
7. Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation.
Hashimoto T; Tayama M; Miyazaki M; Yoneda Y; Yoshimoto T; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 Oct; 13(3):205-8. PubMed ID: 8554657
[TBL] [Abstract][Full Text] [Related]
8. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats.
Chang L; Ernst T; Osborn D; Seltzer W; Leonido-Yee M; Poland RE
Arch Neurol; 1998 Mar; 55(3):305-11. PubMed ID: 9520004
[TBL] [Abstract][Full Text] [Related]
9. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
Fitzgerald KD; Moore GJ; Paulson LA; Stewart CM; Rosenberg DR
Biol Psychiatry; 2000 Feb; 47(3):174-82. PubMed ID: 10682215
[TBL] [Abstract][Full Text] [Related]
10. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
11. Regional variations and age-related changes detected with magnetic resonance spectroscopy in the brain of healthy dogs.
Ono K; Kitagawa M; Ito D; Tanaka N; Watari T
Am J Vet Res; 2014 Feb; 75(2):179-86. PubMed ID: 24471754
[TBL] [Abstract][Full Text] [Related]
12. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopic observations of epilepsia partialis continua in children.
Park YD; Allison JD; Weiss KL; Smith JR; Lee MR; King DW
J Child Neurol; 2000 Nov; 15(11):729-33. PubMed ID: 11108506
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in patients with ischemic stroke.
Federico F; Conte C; Simone IL; Giannini P; Liguori M; Picciola E; Tortorella C; Ferrari E
Ital J Neurol Sci; 1994 Nov; 15(8):413-20. PubMed ID: 7875959
[TBL] [Abstract][Full Text] [Related]
15. [Developmental changes in proton MR spectroscopy of the brain].
Hashimoto T; Tayama M; Miyazaki M; Fujii E; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
No To Hattatsu; 1994 Jan; 26(1):26-31. PubMed ID: 8280443
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy.
Thompson JE; Castillo M; Kwock L; Walters B; Beach R
AJR Am J Roentgenol; 1998 Mar; 170(3):771-6. PubMed ID: 9490972
[TBL] [Abstract][Full Text] [Related]
17. Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy.
Hashimoto T; Tayama M; Miyazaki M; Yoneda Y; Yoshimoto T; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
J Child Neurol; 1997 Feb; 12(2):91-6. PubMed ID: 9075017
[TBL] [Abstract][Full Text] [Related]
18. Quantitative multivoxel proton spectroscopy of the brain in developmental delay.
Verbruggen KT; Maurits NM; Meiners LC; Brouwer OF; van Spronsen FJ; Sijens PE
J Magn Reson Imaging; 2009 Oct; 30(4):716-21. PubMed ID: 19787717
[TBL] [Abstract][Full Text] [Related]
19. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.
Vielhaber S; Jakubiczka S; Gaul C; Schoenfeld MA; Debska-Vielhaber G; Zierz S; Heinze HJ; Niessen HG; Kaufmann J
Muscle Nerve; 2006 Aug; 34(2):145-52. PubMed ID: 16642499
[TBL] [Abstract][Full Text] [Related]
20. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
Bowen BC; Block RE; Sanchez-Ramos J; Pattany PM; Lampman DA; Murdoch JB; Quencer RM
AJNR Am J Neuroradiol; 1995 Jan; 16(1):61-8. PubMed ID: 7900603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
